In contrast, SNORD33, SNORD66, and SNORD76 exhibited significantly higher expressions in NSCLC patients as compared with healthy controls, suggesting that the elevated expressions of the three genes in plasma might be cancer-associated changes (All P < 0.01). Here, SNORD66 is linked to cancer.